Capital World Investors’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-955,979
Closed -$76.8M 539
2024
Q2
$76.8M Buy
955,979
+12,863
+1% +$1.18M 0.01% 355
2024
Q1
$87M Buy
943,116
+4,369
+0.5% +$419K 0.01% 360
2023
Q4
$99.1M Buy
938,747
+14,027
+2% +$1.41M 0.02% 339
2023
Q3
$100M Buy
924,720
+40
+0% +$4.42K 0.02% 333
2023
Q2
$99.8M Sell
924,680
-466,048
-34% -$52.4M 0.02% 334
2023
Q1
$173M Sell
1,390,728
-677,520
-33% -$93M 0.04% 290
2022
Q4
$311M Buy
2,068,248
+443,586
+27% +$68.3M 0.07% 239
2022
Q3
$219M Buy
1,624,662
+880,179
+118% +$135M 0.05% 258
2022
Q2
$111M Buy
744,483
+161
+0% +$24.6K 0.02% 324
2022
Q1
$127M Sell
744,322
-1,152,076
-61% -$194M 0.02% 337
2021
Q4
$489M Sell
1,896,398
-1,014,544
-35% -$278M 0.08% 216
2021
Q3
$795M Sell
2,910,942
-495,408
-15% -$157M 0.14% 166
2021
Q2
$763M Buy
3,406,350
+2,973,468
+687% +$561M 0.13% 172
2021
Q1
$47.3M Buy
+432,882
New +$46M 0.01% 443

Other funds holding BNTX

Capital World Investors's BNTX Position: Q3 2024 in Review

Capital World Investors sold out of BioNTech (BNTX) in Q3 2024, closing a stake of 955,979 shares — an estimated $76.8M sold.

Capital World Investors first reported a position in BNTX in Q1 2021 and held it in 14 quarters. The position peaked at $795M in Q3 2021. 296 funds tracked by Wall St. Rank hold BNTX as of Q3 2024.

  • Capital World Investors reported no remaining BioNTech position as of Q3 2024 after selling out during the quarter.
  • Capital World Investors sold 955,979 BioNTech shares in Q3 2024, an estimated $76.8M.
  • Capital World Investors first reported a position in BioNTech in Q1 2021 and held it in 14 quarters.
  • Capital World Investors's BioNTech position peaked at $795M in Q3 2021.
  • 296 funds tracked by Wall St. Rank held BioNTech as of Q3 2024.

Based on Capital World Investors's 13F filing for Q3 2024, filed 13 Nov 2024.